
The Cost of Undetected Data Anomalies in Clinical Trials
In clinical trials, every data point can be valid on its own, yet together they can reveal a pattern that raises serious clinical questions. Edit
Exciting News! Saama’s Smart ClinSAP Wins the 2026 CDISC AI Innovation Challenge
A Saama company that offers data analytics solutions and services for banking and capital markets, consumer goods, insurance, the public sector, and more.

In clinical trials, every data point can be valid on its own, yet together they can reveal a pattern that raises serious clinical questions. Edit

Clinicians are burned out today as they spend too much time on their screens instead of patients- not because they care about their patients’ well-being.

The afternoon that costs you four months. Why Metadata Reuse Breaks at Scale in Global Study Builds Meta description: Most sponsors already have a global

Somewhere in every clinical trial, a patient tells an investigator they have a “splitting headache.” Another says their head is “pounding.” A third calls it

Labs and adverse events (AEs) are two views of the same patient. When medical monitors, safety reviewers, or CRAs assess them through separate workflows —

Every few months, a new vendor promises a “zero touch” clinical coding automation pipeline: feed in raw text, let the algorithm match it against MedDRA

For 60 years, clinical trial data has moved on a one-way delay: sites collect it, sponsors analyze it, and only then does it reach the

There’s a quiet assumption baked into most “AI for clinical programming” pitches: that the hard part is generating code. Well, it isn’t. Any model can

Clinical development has always been expensive. But in 2026, the economics are drawing sharper attention. Developing a single new molecular entity now routinely requires between
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.